MiR-7 Inhibits Progression of Hepatocarcinoma by Targeting KLF-4 and Promises a Novel Diagnostic Biomarker

Cancer Cell International - United Kingdom
doi 10.1186/s12935-017-0386-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MIR-138-5P Inhibits the Progression of Prostate Cancer by Targeting FOXC1

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2020English

miR-326 Inhibits the Progression of Papillary Thyroid Carcinoma by Targeting MAPK1 and ERBB4

Neoplasma
Cancer Research
2020English

miR‑342 Inhibits Glioma Cell Proliferation by Targeting GPRC5A

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26

Frontiers in Immunology
AllergyImmunology
2020English

Silence of miR-32-5p Promotes Endothelial Cell Viability by Targeting KLF2 and Serves as a Diagnostic Biomarker of Acute Myocardial Infarction

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2020English

MiR-34b-3 and miR-449a Inhibit Malignant Progression of Nasopharyngeal Carcinoma by Targeting Lactate Dehydrogenase A

Oncotarget
Oncology
2016English

Circular RNA Hsa_circ_0068033 Acts as a Diagnostic Biomarker and Suppresses the Progression of Breast Cancer Through Sponging miR-659

OncoTargets and Therapy
OncologyPharmacology
2020English

miR-1271 Inhibits OSCC Cell Growth and Metastasis by Targeting ALK

Neoplasma
Cancer Research
2015English

miR‑671‑3p Is Downregulated in Non‑small Cell Lung Cancer and Inhibits Cancer Progression by Directly Targeting CCND2

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy